Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
Edwards Lifesciences’ roots date to 1958, when Miles “Lowell” Edwards set out to build the first artificial heart.
Edwards was a 60-year-old, recently retired engineer holding 63 patents in an array of industries, with an entrepreneurial spirit and a dream of helping patients with heart disease. His fascination with healing the heart was sparked in his teens, when he suffered two bouts of rheumatic fever, which can scar heart valves and eventually cause the heart to fail.
We partner with physicians to innovate products designed to help patients live longer, healthier and more productive lives. We focus on medical technologies that address large and growing patient populations in which there are significant unmet clinical needs.
At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fighting cardiovascular disease.
Helping patients is our life work, and life is now.
Our corporate headquarters are located in Irvine, California, and we supply products and technologies to clinicians in nearly 100 countries around the world.
As part of our commitment to our global community, we provide philanthropic support to important health-related and community causes. The Edwards Lifesciences Foundation supports advancements in knowledge and improvements in quality of life.